Page last updated: 2024-08-23

acitretin and Pityriasis Rubra Pilaris

acitretin has been researched along with Pityriasis Rubra Pilaris in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (7.89)18.2507
2000's13 (34.21)29.6817
2010's14 (36.84)24.3611
2020's8 (21.05)2.80

Authors

AuthorsStudies
Baker, CS; Daniel, BS; Foley, P; Ringin, S1
Katharina, M; Martin, L; Matthias, B; Sylvia, S; Ulrich, M1
Gamonal, ACC; Gamonal, SBL; Marques, NCV; Pereira, HMB1
Su-Chun, H; Xiao-Yan, W; Ying, Y; Yu-Hua, L1
Crespo-Erchiga, A; Gomez-Moyano, E1
Akin, R; Cook, E; Kollipara, S; Tarbox, M; Tran, KW1
Camela, E; De Fata Salvatores, G; Di Caterino, P; Fabbrocini, G; Lo Presti, M; Megna, M; Miano, C1
Kromer, C; Lippert, U; Mössner, R; Schön, MP1
Chia, SY; Koh, MJA; Rafi'ee, K; Tan, EC; Wei, H; Wong, GHZ1
Atzori, L; Ferreli, C; Lappi, A; Pilloni, L; Pinna, AL; Rongioletti, F; Zanniello, R1
Chastagner, M; Hoelt, P; Jullien, D; Kanitakis, J; Villani, AP1
Duran, VD; Gajinov, ZT; Matić, MB; Prcić, ST; Vucković, N; Vujanović, LM1
Dalmau, J; Fernández-Figueras, MT; López-Ferrer, A; Puig, L1
Abbas, O; Kibbi, AG; Kurban, M; Marrouche, N1
Chung, PK; van der Kuip, M; Vergunst, CE1
Byekova, Y; Sami, N1
Carvalho, S; Mota, F; Sanches, M; Selores, M1
Kim, J; Kumarasinghe, SP; Papadimitriou, J; Yu, L1
Généreux, AD; Wetter, DA1
Chen, W; Cheng, YW; Chiu, HC; Huang, PH; Lee, JY; Lin, WL; Shih, IH; Yang, CC; Yu, YS1
Doughty, LE; Stetson, CL; Wells, MJ1
Goldberg, LJ; Koff, AB; Sebastian, A1
Antonelli, G; Di Giampetruzzi, AR; Didona, B; Garcovich, A; Garcovich, S1
Chiu, HY; Tsai, TF1
Artik, S; Megahed, M; Ruzicka, T1
White, KL1
Gilmore, RE1
Brzezińska-Wcisło, L; Krauze, E; Lis-Swiety, A; Wcisło-Dziadecka, D1
George, SJ; Hsu, S; Lu, R1
Argyriou, G; Christofidou, E; Gregoriou, S; Rigopoulos, D; Vranou, A1
Davis, KF; Meshkinpour, A; Murase, JE; Rosenberg, FR; Sorenson, EP; Wu, JJ1
van de Kerkhof, PC; van Dooren-Greebe, RJ1
Jacyk, WK1
Logan, RA; Varma, S1
Kirby, B; Watson, R1
Ehnis, A; Herbst, RA; Kapp, A; Kiehl, P; Vogelbruch, M; Weiss, J1
Bröcker, EB; Hamm, H; Hofmann, UB; Terheyden, P1
Hertel, K; Höffken, K; Kloos, C; Metzner, U; Müller, UA; Raabe, G; Schreiber, J1

Reviews

2 review(s) available for acitretin and Pityriasis Rubra Pilaris

ArticleYear
Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Acitretin; Dermatologic Agents; Humans; Pityriasis Rubra Pilaris; Ultraviolet Therapy; Ustekinumab

2020
Exanthematic pityriasis rubra pilaris.
    The British journal of dermatology, 1999, Volume: 141, Issue:4

    Topics: Acitretin; Facial Dermatoses; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Remission, Spontaneous; Scalp Dermatoses

1999

Other Studies

36 other study(ies) available for acitretin and Pityriasis Rubra Pilaris

ArticleYear
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital.
    Dermatologic therapy, 2021, Volume: 34, Issue:6

    Topics: Acitretin; Adult; Australia; Child; Humans; Pityriasis Rubra Pilaris; Retrospective Studies; Tertiary Care Centers

2021
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Pediatric dermatology, 2022, Volume: 39, Issue:4

    Topics: Acitretin; Adult; Child; Child, Preschool; Female; Humans; Pityriasis Rubra Pilaris; Psoriasis; Ustekinumab

2022
Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.
    Dermatologic therapy, 2022, Volume: 35, Issue:12

    Topics: Acitretin; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Pityriasis Rubra Pilaris; RNA, Messenger; Ustekinumab

2022
A case of pityriasis rubra pilaris treated with tofacitinib after failure with acitretin and ixekizumab.
    The Australasian journal of dermatology, 2023, Volume: 64, Issue:3

    Topics: Acitretin; Antibodies, Monoclonal, Humanized; Humans; Pityriasis Rubra Pilaris

2023
Erythroderma secondary to pityriasis rubra pilaris.
    The Indian journal of medical research, 2019, Volume: 150, Issue:2

    Topics: Acitretin; Aged; Dermatitis, Exfoliative; Dermoscopy; Female; Humans; Pityriasis Rubra Pilaris; Spain

2019
A case of resistant pityriasis ribra pilaris responsive to combination acitrentin and ustekinumab.
    Dermatology online journal, 2020, Mar-15, Volume: 26, Issue:3

    Topics: Acitretin; Aged, 80 and over; Dermatologic Agents; Drug Therapy, Combination; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Ustekinumab

2020
Treatment of pityriasis rubra pilaris: a case series of 28 patients.
    European journal of dermatology : EJD, 2020, Oct-01, Volume: 30, Issue:5

    Topics: Acitretin; Biological Products; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Retrospective Studies; Smoking; Ustekinumab

2020
CARD14-associated papulosquamous eruption (CAPE) in a toddler responding to treatment with acitretin.
    Pediatric dermatology, 2021, Volume: 38, Issue:4

    Topics: Acitretin; CARD Signaling Adaptor Proteins; Child, Preschool; Female; Guanylate Cyclase; Humans; Membrane Proteins; Pityriasis Rubra Pilaris

2021
Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
    Dermatologic therapy, 2018, Volume: 31, Issue:5

    Topics: Acitretin; Dermatitis, Exfoliative; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris

2018
Successful treatment of TNFα inhibitor-resistant pityriasis rubra pilaris with ixekizumab and acitretin.
    European journal of dermatology : EJD, 2019, 04-01, Volume: 29, Issue:2

    Topics: Acitretin; Adalimumab; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Resistance; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; Tumor Necrosis Factor-alpha

2019
Drug-related pityriasis rubra pilaris with acantholysis.
    Vojnosanitetski pregled, 2013, Volume: 70, Issue:9

    Topics: Acantholysis; Acitretin; Anticholesteremic Agents; Head; Humans; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Simvastatin; Thorax; Treatment Outcome

2013
Pityriasis rubra pilaris triggered by photodynamic therapy with response to tumor necrosis factor α-blocking agents and acitretin.
    Cutis, 2014, Volume: 93, Issue:3

    Topics: Acitretin; Antibodies, Monoclonal; Antirheumatic Agents; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Keratolytic Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha

2014
Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon.
    International journal of dermatology, 2014, Volume: 53, Issue:4

    Topics: Acitretin; Administration, Cutaneous; Adolescent; Adult; Aged; Child; Child, Preschool; Emollients; Eosinophils; Female; Humans; Isotretinoin; Keratolytic Agents; Lebanon; Male; Middle Aged; Nicotinic Acids; Pityriasis Rubra Pilaris; Retrospective Studies; Steroids; Young Adult

2014
[A girl with desquamation of hands and feet].
    Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158

    Topics: Acitretin; Child, Preschool; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Treatment Outcome

2014
Successful response of refractory type I adult-onset pityriasis rubra pilaris with ustekinumab and acitretin combination therapy.
    The Journal of dermatology, 2015, Volume: 42, Issue:8

    Topics: Acitretin; Aged; Dermatologic Agents; Drug Therapy, Combination; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Ustekinumab

2015
Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2016, Volume: 25, Issue:1

    Topics: Acitretin; Humans; Keratolytic Agents; Male; Pityriasis Rubra Pilaris; Young Adult

2016
Cyclical Inguinal Keratoderma: A New Clinical Entity or a Variant of Pityriasis Rubra Pilaris?
    The Australasian journal of dermatology, 2016, Volume: 57, Issue:3

    Topics: Acitretin; Biopsy, Needle; Diagnosis, Differential; Humans; Immunohistochemistry; Keratosis; Male; Middle Aged; Pityriasis Rubra Pilaris; Pruritus; Recurrence; Scrotum; Skin Diseases; Thigh; Treatment Outcome

2016
Widespread erythematous skin eruption.
    The Journal of family practice, 2017, Volume: 66, Issue:3

    Topics: Acitretin; Biopsy; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; Skin; Treatment Outcome; Vitamin A

2017
Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:6

    Topics: Acitretin; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Pityriasis Rubra Pilaris; Retrospective Studies; Taiwan

2008
Pityriasis rubra pilaris with epidermolytic hyperkeratosis.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:10

    Topics: Acitretin; Erythema; Humans; Hyperkeratosis, Epidermolytic; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Skin

2008
PRP with subcorneal acantholysis: case report and review.
    Journal of cutaneous pathology, 2010, Volume: 37, Issue:1

    Topics: Acantholysis; Acitretin; Aged; Diagnosis, Differential; Epidermis; Female; Humans; Keratolytic Agents; Pemphigus; Pityriasis Rubra Pilaris

2010
Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:8

    Topics: Acitretin; Adult; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha

2010
Pityriasis rubra pilaris with polyarthritis treated with adalimumab.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:1

    Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Young Adult

2013
[Pityriasis rubra pilaris. Case reports and review of the literature].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:9

    Topics: Acitretin; Administration, Oral; Adult; Aged; Biopsy; Chronic Disease; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Prognosis; PUVA Therapy; Skin; Time Factors

2003
Pityriasis rubra pilaris.
    Dermatology online journal, 2003, Volume: 9, Issue:4

    Topics: Acitretin; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Ointments; Pityriasis Rubra Pilaris; Tacrolimus

2003
Living with pityriasis rubra pilaris.
    Dermatology nursing, 2005, Volume: 17, Issue:5

    Topics: Acitretin; Activities of Daily Living; Adaptation, Psychological; Aged; Attitude to Health; Biopsy; Cost of Illness; Humans; Keratolytic Agents; Male; Patient Education as Topic; Pityriasis Rubra Pilaris; Rare Diseases; Self Care; Self-Help Groups; Skin Care; Social Support

2005
[Diagnostic and therapeutic difficultes in pityriasis rubra pilaris--case report].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 19, Issue:113

    Topics: Acitretin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Carbonate; Cefuroxime; Chronic Disease; Diagnosis, Differential; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Hydroxycholecalciferols; Keratolytic Agents; Male; Methylprednisolone; Middle Aged; Pityriasis Rubra Pilaris; Ranitidine

2005
Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab.
    Dermatology online journal, 2006, May-30, Volume: 12, Issue:4

    Topics: Acitretin; Anti-Inflammatory Agents; Antibodies, Monoclonal; Dermatologic Agents; Drug Resistance; Humans; Infliximab; Keratolytic Agents; Male; Middle Aged; Pityriasis Rubra Pilaris; Tumor Necrosis Factor-alpha

2006
Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:3

    Topics: Acitretin; Administration, Topical; Adult; Dermatologic Agents; Face; Humans; Keratolytic Agents; Male; Ointments; Pityriasis Rubra Pilaris; Scalp; Skin; Tacrolimus

2007
Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy.
    Archives of dermatology, 2007, Volume: 143, Issue:12

    Topics: Acitretin; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Male; Middle Aged; Pityriasis Rubra Pilaris; Receptors, Tumor Necrosis Factor; Treatment Outcome

2007
Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris.
    Journal of the American Academy of Dermatology, 1995, Volume: 32, Issue:2 Pt 2

    Topics: Acetabulum; Acitretin; Adolescent; Adult; Azathioprine; Child; Etretinate; Exostoses; Femur Neck; Follow-Up Studies; Humans; Hyperostosis; Male; Methotrexate; Pityriasis Rubra Pilaris; Retinoids; Tretinoin

1995
Pityriasis rubra pilaris in black South Africans.
    Clinical and experimental dermatology, 1999, Volume: 24, Issue:3

    Topics: Acitretin; Adolescent; Adult; Age of Onset; Black People; Child; Child, Preschool; Dermatologic Agents; Disease Progression; Emollients; Female; Humans; Infant; Keratolytic Agents; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Prospective Studies; South Africa; Treatment Outcome; Treatment Refusal

1999
Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01)
    The British journal of dermatology, 2000, Volume: 142, Issue:2

    Topics: Acitretin; Child; Combined Modality Therapy; Female; Humans; Keratolytic Agents; Pityriasis Rubra Pilaris; Ultraviolet Therapy

2000
Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris.
    The British journal of dermatology, 2000, Volume: 142, Issue:3

    Topics: Acitretin; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Middle Aged; Pityriasis Rubra Pilaris; PUVA Therapy

2000
[Erythroderma after corticosteroid withdrawal in papulosquamous dermatosis in children. Diagnosis: pityriasis rubra pilaris, classic juvenile type].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:11

    Topics: Acitretin; Adult; Age Factors; Anti-Inflammatory Agents; Child, Preschool; Dermatitis, Exfoliative; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Methotrexate; Pityriasis Rubra Pilaris; Prednisolone; PUVA Therapy; Retinoids; Substance Withdrawal Syndrome

2001
[Paraneoplastic pityriasis rubra pilaris in metastatic adenocarcinoma without diagnosable primary].
    Deutsche medizinische Wochenschrift (1946), 2002, Mar-01, Volume: 127, Issue:9

    Topics: Acitretin; Adenocarcinoma; Aged; Anti-Inflammatory Agents; Biopsy; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Keratolytic Agents; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Pityriasis Rubra Pilaris; Prednisolone; Skin

2002